Recent Finacing
Recent Raise
Ariel's ADVANCE platform combines genetic and clinical data with AI to detect early disease signals, infer patient-specific biological dysfunction, and provide decision support for targeted therapies.
Focus Areas
Recent Investors
Funding round
Investor
See the team members at Ariel Precision Medicine.
